Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson's Disease

NCT02642393 is registered in ClinicalTrials.gov with Michael Alan Schwarzschild as lead sponsor.

NCT NCT02642393
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02642393 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Placebo-controlled Trial of Urate-elevating Inosine Treatment to Slow Clinical Decline in Early Parkinson's Disease
Lead sponsor
Michael Alan Schwarzschild
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
June 30, 2019
Enrollment
298 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease